$0.0381
0.0005[1.33%]
Last update: 1:08PM Get Real Time Here
Navidea Biopharmaceutical
(OTCPK:NAVB)Navidea Biopharmaceutical Stock (OTC:NAVB), Earnings Estimates, EPS, and Revenue
Navidea Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.020
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$0.6K
Analyze the earnings history of Navidea Biopharmaceutical using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | NAVB | Q1 | -$0.09 | — | — | — | $0.00 | — | — | — | Get Alert |
| 05/07/2024 | PM | NAVB | Q4 | -$0.11 | — | — | — | $610.00 | — | — | — | Get Alert |
| 11/14/2023 | AM | NAVB | Q3 | -$0.25 | — | -$0.02 | — | $7.52K | — | $0.00 | — | Get Alert |
| 08/11/2023 | AM | NAVB | Q2 | -$0.10 | — | -$0.03 | — | $57.53K | — | $0.00 | — | Get Alert |
| 05/11/2023 | PM | NAVB | Q1 | -$0.10 | — | -$0.09 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/21/2023 | PM | NAVB | Q4 | -$0.12 | — | -$0.11 | — | $50.35K | — | $610.00 | — | Get Alert |
| 11/14/2022 | AM | NAVB | Q3 | -$0.08 | — | -$0.25 | — | $96.38K | — | $7.52K | — | Get Alert |
| 08/15/2022 | AM | NAVB | Q2 | -$0.09 | — | -$0.10 | — | $261.05K | — | $57.53K | — | Get Alert |
| 05/12/2022 | AM | NAVB | Q1 | -$0.11 | — | -$0.10 | — | $123.74K | — | $0.00 | — | Get Alert |
| 03/23/2022 | AM | NAVB | Q4 | -$0.11 | — | -$0.12 | — | $219.25K | — | $50.35K | — | Get Alert |
| 11/10/2021 | PM | NAVB | Q3 | -$0.13 | -$0.11 | -$0.08 | 27.27% | $268.39K | — | $96.38K | — | Get Alert |
| 08/11/2021 | PM | NAVB | Q2 | -$0.11 | -$0.08 | -$0.09 | -12.50% | $271.10K | — | $261.05K | — | Get Alert |
| 05/11/2021 | PM | NAVB | Q1 | -$0.13 | -$0.08 | -$0.12 | -50.00% | $156.27K | — | $123.74K | — | Get Alert |
| 03/24/2021 | PM | NAVB | Q4 | -$0.15 | -$0.12 | -$0.11 | 8.33% | $119.30K | $600.00K | $219.25K | -63.46% | Get Alert |
| 11/12/2020 | PM | NAVB | Q3 | -$0.17 | -$0.09 | -$0.13 | -44.44% | $236.81K | $150.00K | $268.39K | 78.93% | Get Alert |
| 08/13/2020 | PM | NAVB | Q2 | -$0.24 | — | -$0.11 | — | $260.09K | $156.00K | $271.10K | 73.78% | Get Alert |
| 05/14/2020 | PM | NAVB | Q1 | -$0.24 | — | -$0.13 | — | $136.03K | — | $156.27K | — | Get Alert |
| 03/11/2020 | PM | NAVB | Q4 | -$0.40 | -$0.12 | -$0.15 | -25.00% | $119.32K | — | $119.30K | — | Get Alert |
| 11/07/2019 | PM | NAVB | Q3 | -$0.40 | -$0.17 | -$0.17 | 0.00% | $231.46K | — | $236.81K | — | Get Alert |
FAQ
When is Navidea Biopharmaceutical (OTCPK:NAVB) reporting earnings?
Navidea Biopharmaceutical (NAVB) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Navidea Biopharmaceutical (OTCPK:NAVB)?
The Actual EPS was $-0.02, which missed the estimate of $0.00.
What were Navidea Biopharmaceutical’s (OTCPK:NAVB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.